(Q49098748)

English

Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

1 reference

based on heuristic

inferred from title

Christina Peters

13

object named as

Christina Peters

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

author name string

Heidrun Boztug

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Cäcilia Karitnig-Weiß

2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Bernd Ausserer

3

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Ellen D Renner

4

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Michael H Albert

5

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Julie Sawalle-Belohradsky

6

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Bernd H Belohradsky

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Georg Mann

8

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Ernst Horcher

9

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Alexandra Rümmele-Waibel

10

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Rene Geyeregger

11

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Karoly Lakatos

12

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Anita Lawitschka

14

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Susanne Matthes-Martin

15

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

publication date

16 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Pediatric Hematology and Oncology

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

29

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

585-594

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Hyperimmunoglobulin E syndromes in pediatrics.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

STAT3 mutations in the hyper-IgE syndrome

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Combined immunodeficiency associated with DOCK8 mutations

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

DOCK8 immune deficiency as a model for primary cytoskeletal dysfunction.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

DOCK8 deficiency.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

The essential role of DOCK8 in humoral immunity

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Additional diverse findings expand the clinical presentation of DOCK8 deficiency

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Acquisition of cytomegalovirus infection from birth to 10 years: a longitudinal serologic study.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Epidemiological studies of Epstein–Barr herpesvirus infection in Western Australia

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Dedicator of cytokinesis 8 (DOCK8) deficiency

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Cutaneous manifestations of DOCK8 deficiency syndrome

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.714844

21 January 2018

Identifiers

10.3109/08880018.2012.714844

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22897717

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49098748&oldid=2098350888"